An Energetic View on Creativity, Psychopathology and Intelligence: The Brain2Business Study
B2B
1 other identifier
interventional
200
1 country
1
Brief Summary
The interventional part of the study aims to assess the acute effect of the Brain2Business (B2B) tool on creative thinking (primary objective) in adults with psychological disorders. Additionally, the study assesses the B2B effects on energy-related sensations and metabolism, technique adherence, gratefulness and goal-directed activation (secondary objectives) in adults with and without psychological disorders. The observational part of the study primarily aims to investigate the link between psychopathology, intelligence, energy-related sensations and metabolism validating the "c factor mito-bioenergetics" (CMB) model in a sample of adults with and without psychological disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 19, 2022
CompletedFirst Submitted
Initial submission to the registry
July 30, 2022
CompletedFirst Posted
Study publicly available on registry
September 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 4, 2023
CompletedOctober 26, 2023
October 1, 2023
1.2 years
July 30, 2022
October 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
General creative thinking as assessed with the PTT creativity examination
The PTT creativity examination measures general creative thinking in psychotherapeutic techniques (PTT) using a composite measure of a newly developed objective and self-reported creative thinking assessments across two PTT. The composite score is calculated by averaging z-standardized objective and self-reported creative thinking assessments from both PTT. The z-standardized outcome value has a mean of 0 and SD of 1 with a probable range between -3 and +3. Higher scores mean a better outcome. The assessment include the generated ideas (a) for pleasurable activities as a component of behavioral activation (PA-BA) and (b) for a gratefulness exercise (GE). The score will be adjusted for baseline general creative thinking.
Measured in the lab-session (time point 4)
Secondary Outcomes (27)
Objective creative thinking as assessed with the PTT creativity examination - Objective creativity subscore
Measured in the lab-session (time point 4)
Self-report creative thinking as assessed with the PTT creativity examination - Self-reported creativity subscore
Measured in the lab-session (time point 4)
Top 3 creativity evaluation
Measured in the lab-session (time point 4)
PTT creativity examination - Originality subscore
Measured in the lab-session (time point 4)
Eureka moment assessment
Measured in the lab-session (time point 4)
- +22 more secondary outcomes
Other Outcomes (9)
Heart rate variability
Change from baseline (time point 2) to exercise tasks (time point 4) within the lab-based session
Core body temperature
Change from baseline (time point 2) to exercise tasks (time point 4) within the lab-based session
Blood oxygenation variability
Change from baseline (time point 2) to exercise tasks (time point 4) within the lab-based session
- +6 more other outcomes
Study Arms (2)
Brain2Business (B2B)
EXPERIMENTALThe Brain2Business (B2B) technique aims to improve creative thinking. It is a game-based "conceptual combination" method that is performed by the participant with support of one trained B2B administrator in a laboratory session and without support in 5 at-home sessions. In this technique, thirty-six different images are randomly selected on a board by throwing two dices. Inspired by these images, participants are asked to create new ideas regarding three questions for a total of at least 39 minutes over a period of 5 days. One question is from a standardized creativity test and two questions are part of psychotherapeutic techniques (idea generation for pleasurable activities within behavioral activation (PA-BA) and for a gratefulness exercise (GE)). The B2B technique is based on the principles of solo brainstorming (SBS). A trained B2B administrator is documenting the answers of the participant, and mentioning the principles of SBS (see SBS group).
Solo Brainstorming (SBS)
ACTIVE COMPARATORSolo brain storming (SBS) is the active control condition. The technique aims to improve creative thinking through the principles of SBS. SBS principles include i) idea quantity goes before quality, ii) no criticism and evaluation of ideas during idea generation, iii) original ideas are encouraged. The principles are provided to participants in the same way, with the same questions to be answered, and over the same time period as in the B2B group. A trained SBS administrator is documenting the answers of the participant, and mentioning the principles of SBS.
Interventions
The 5-day intervention integrates a brief behavioral activation (BA) and a gratefulness exercise (GE) program. BA is composed of a lab-based idea generation and planning phase as well as a home-based performing phase with regard to pleasurable activities. GE is a idea generation task about aspects in life participants are grateful for about. It is performed once lab-based and daily with a home-based diary.
Eligibility Criteria
You may qualify if:
- Individuals with and without a diagnosed psychiatric disorder (lifetime or current)
You may not qualify if:
- Acute suicidality
- Self-reported diagnosed neurological disorders that interfere with the study procedures
- Insufficient German language
- Vulnerable participants (e.g. participants with any indications for an incapability of judgement)
- Caffeine, tobacco consumption and physical activity two hours before the lab-based session starts (only for additional biomarker analyses)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Psychiatrische Dienste Thurgaulead
- Brain2Go AGcollaborator
- greenTEG AGcollaborator
- SOMNOmedics GmbHcollaborator
Study Sites (1)
Psychiatric Service Thurgau
Münsterlingen, Thurgau, 8596, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rainer Krähenmann, PD
Psychiatrische Dienste Thurgau
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Based on the behavioral intervention, the administrator of the intervention who is intrinsically also the outcome assessor of the primary outcome cannot be masked. Participants are masked as they are not aware about their treatment condition. Self-rated questionnaire-based outcome measures are not subject to bias as participants are masked.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical director of Psychiatric Services Thurgau (PD Dr.)
Study Record Dates
First Submitted
July 30, 2022
First Posted
September 19, 2022
Study Start
July 19, 2022
Primary Completion
September 29, 2023
Study Completion
October 4, 2023
Last Updated
October 26, 2023
Record last verified: 2023-10